Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

29 Oct 2018 07:00

RNS Number : 3880F
Harvey Nash Group PLC
29 October 2018
 

29 October 2018

 

Director/PDMR Shareholding

Harvey Nash Group Plc

("the Company")

Notification of Transaction by Directors

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was advised on 26 October 2018 that Albert Ellis, Simon Wassall and Mark Garratt had acquired ordinary shares in London on 26 October 2018 at a price of £0.05 per ordinary share as a result of the exercise of options granted under the Company's Performance Share Plan which became exercisable as a result of the offer by The Power of Talent Ltd being declared wholly unconditional on 26 October 2018:

Director

Number of shares purchased

Price per share

Resulting holding

Albert Ellis

1,385,499

£0.05

2,267,084*

Simon Wassall

930,215

£0.05

1,259,331

Mark Garratt

381,229

£0.05

416,787

*Includes 658,923 ordinary shares held by family members.

The notification below provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1

Details of the person discharging managerial responsibility

a)

Name

Albert Ellis

2

Reason for the notification

a)

Position/status

Chief Executive

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

1,385,499

£69,274.95

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Simon Wassall

2

Reason for the notification

a)

Position/status

European Managing Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

930,215

£46,510.75

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Garratt

2

Reason for the notification

a)

Position/status

Group Finance Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

381,229

£19,061.45

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

Contact:

Mark Garratt, Group Finance Director - 020 7333 0033

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFEUFMMFASEES
Date   Source Headline
29th May 20159:37 amRNSHolding(s) in Company
19th May 201511:08 amRNSHolding(s) in Company
6th May 20153:32 pmRNSGrant of Share Awards to Directors
1st May 20152:50 pmRNSDirector/PDMR Shareholding
1st May 20157:00 amRNSTotal Voting Rights
30th Apr 20157:00 amRNSFinal Results
13th Apr 20155:01 pmRNSHolding(s) in Company
9th Apr 201510:45 amRNSHolding(s) in Company
1st Apr 201511:27 amRNSDirector/PDMR Shareholding
1st Apr 20157:00 amRNSTotal Voting Rights
4th Mar 20152:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20157:00 amRNSTotal Voting Rights
27th Feb 20157:00 amRNSTrading Update
3rd Feb 20154:16 pmRNSHolding(s) in Company
3rd Feb 20151:46 pmRNSHolding(s) in Company
2nd Feb 201511:29 amRNSDirector/PDMR Shareholding
2nd Feb 20157:00 amRNSTotal Voting Rights
5th Jan 20151:22 pmRNSDirector/PDMR Shareholding
2nd Jan 20157:00 amRNSTotal Voting Rights
12th Dec 20147:00 amRNSBlocklisting Interim Review
11th Dec 20149:52 amRNSGrant of Share Awards to Directors
8th Dec 20143:52 pmRNSHolding(s) in Company
2nd Dec 201410:06 amRNSDirector/PDMR Shareholding
1st Dec 20147:00 amRNSTotal Voting Rights
25th Nov 20143:49 pmRNSDirector Declaration
25th Nov 20147:00 amRNSTrading Statement
18th Nov 20144:42 pmRNSHolding(s) in Company
31st Oct 20147:00 amRNSTotal Voting Rights
30th Oct 20145:32 pmRNSDirector/PDMR Shareholding
6th Oct 201411:47 amRNSDirector/PDMR Shareholding
1st Oct 20147:00 amRNSTotal Voting Rights
30th Sep 20147:00 amRNSHalf Yearly Report
17th Sep 201411:19 amRNSHolding(s) in Company
2nd Sep 20145:48 pmRNSHolding(s) in Company
2nd Sep 20141:29 pmRNSDirector/PDMR Shareholding
1st Sep 20147:00 amRNSTotal Voting Rights
22nd Aug 20147:00 amRNSJapanese acquisition extends reach across Asia
20th Aug 20147:00 amRNSTrading Update and Notice of Results
1st Aug 20147:00 amRNSTotal Voting Rights
31st Jul 20143:33 pmRNSEBT Share Transfer
31st Jul 20147:00 amRNSDirector/PDMR Shareholding
11th Jul 20149:58 amRNSHolding(s) in Company
10th Jul 20143:28 pmRNSHolding(s) in Company
4th Jul 201410:14 amRNSDirector/PDMR Shareholding
4th Jul 201410:08 amRNSEBT Share Purchase
3rd Jul 201411:03 amRNSDirectorate Change
3rd Jul 201410:59 amRNSResult of AGM
2nd Jul 20144:11 pmRNSHolding(s) in Company
1st Jul 20147:00 amRNSTotal Voting Rights
27th Jun 20144:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.